Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
2021 · Annals of the Rheumatic Diseases · 239 citations
https://doi.org/10.1136/annrheumdis-2020-219601
A
Atul Deodhar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
200
Papers
5.8K
Citations
35
h-index
66
i10-index
Atul Deodhar is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Spondyloarthritis Studies and Treatments & Rheumatoid Arthritis Research and Therapies & Psoriasis: Treatment and Pathogenesis. The author has an h-index of 35, co-authored 170 publications.
ORCID: 0000-0002-2130-1246Papers by this author
worksEffects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
2008 · Annals of the Rheumatic Diseases · 136 citations
https://doi.org/10.1136/ard.2007.084426
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis
2020 · Clinical Rheumatology · 28 citations
https://doi.org/10.1007/s10067-020-04970-3
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure
2022 · Annals of the Rheumatic Diseases · 19 citations
https://doi.org/10.1136/annrheumdis-2021-222027
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
2022 · Arthritis Research & Therapy · 18 citations
https://doi.org/10.1186/s13075-022-02753-6
Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review
2022 · BMC Musculoskeletal Disorders · 15 citations
https://doi.org/10.1186/s12891-022-05073-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat